A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, ASCENDING DOSE STUDY TO EVALUATE EFFICACY, SAFETY, AND TOLERABILITY OF CC 220 IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引：0
|
作者：
Furie, R. [1 ]
Werth, V. P. [2 ,3 ]
Lee, E. [4 ]
Box, E. [5 ]
Fondal, M. [6 ]
Kivitz, A. [7 ]
Chatham, W. W. [8 ]
Kalunian, K. C. [9 ]
Legerton, C. [10 ]
Anolik, J. H. [11 ]
Korish, S. [12 ]
Hough, D. R. [12 ]
Weiswasser, M. [12 ]
Choi, S. [12 ]
Schafer, P. [12 ]
机构：
[1] Hofstra Northwell Sch Med, Northwell Hlth, Div Rheumatol, New Hyde Pk, NY USA
[2] Hosp Univ Penn, Dept Dermatol, 3400 Spruce St, Philadelphia, PA 19104 USA
[3] Vet Adm Med Ctr, Philadelphia, PA 19104 USA
[4] Inland Rheumatol Clin Trials Inc, Upland, CA USA
[5] Carolinas PLLC, Box Arthrit & Rheumatol, Charlotte, NC USA
[6] Arthrit Res & Treatment Ctr, Stockbridge, GA USA
[7] Altoona Ctr Clin Res, Duncansville, PA USA
[8] Univ Alabama Birmingham, Rheumatol & Clin Immunol, Birmingham, AL USA
[9] UC San Diego Hlth, Div Rheumatol, San Diego, CA USA
[10] Low Country Rheumatol PA, Charleston, SC USA
[11] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA
[12] Celgene Corp, Summit, NJ USA
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2016年 / 34卷 / 04期
关键词：
CC-220; Ikaros; cereblon;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5:94
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [41] A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer's Disease
    Galasko, Douglas
    Farlow, Martin R.
    Lucey, Brendan P.
    Honig, Lawrence S.
    Elbert, Donald
    Bateman, Randall
    Momper, Jeremiah
    Thomas, Ronald G.
    Rissman, Robert A.
    Pa, Judy
    Aslanyan, Vahan
    Balasubramanian, Archana
    West, Tim
    Maccecchini, Maria
    Feldman, Howard H.
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [42] Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects
    Vinson, Joe A.
    Burnham, Bryan R.
    Nagendran, Mysore V.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2012, 5 : 21 - 27
  • [43] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
    Croop, R.
    Lipton, R. B.
    Kudrow, D.
    Stock, D. A.
    Kamen, L.
    Conway, C. M.
    Stock, E. G.
    Coric, V.
    Goadsby, P. J.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 28 - 29
  • [44] A phase 2/3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rimegepant for the preventive treatment of migraine
    Croop, R.
    Lipton, R. B.
    Kudrow, D.
    Stock, D. A.
    Kamen, L.
    Conway, C. M.
    Stock, E. G.
    Coric, V
    Goadsby, P. J.
    HEADACHE, 2021, 61 : 98 - 99
  • [45] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
    Croop, Robert
    Lipton, Richard
    Thiry, Alexandra
    Kamen, Lisa
    Coric, Vlad
    Goadsby, Peter
    NEUROLOGY, 2021, 96 (15)
  • [46] A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of AMG 334 for the Prevention of Episodic Migraine
    Sun, H.
    Silberstein, S.
    Dodick, D. W.
    Reuter, U.
    Ashina, M.
    Saper, J. R.
    Cady, R.
    Chon, Y.
    Dietrich, J.
    Lenz, R.
    HEADACHE, 2015, 55 : 132 - 132
  • [47] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
    Croop, R.
    Lipton, R. B.
    Kudrow, D.
    Stock, D. A.
    Kamen, L.
    Conway, C. M.
    Stock, E. G.
    Coric, V.
    Goadsby, P. J.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 19 - 19
  • [48] A phase I, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the pharmacokinetics, safety, and tolerability of oral ceftibuten in healthy adult subjects
    Hernandez-Mitre, Maria Patricia
    Wallis, Steven C.
    Morgan, Elizabeth E.
    Dudley, Michael N.
    Loutit, Jeffery S.
    Griffith, David C.
    Roberts, Jason A.
    Shields, Ryan K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (01)
  • [49] Efficacy and safety of creatine supplementation in childhood-onset systemic lupus erythematosus: a randomized, double-blind, placebo-controlled, crossover trial
    Hayashi, A. P.
    Solis, M. Y.
    Sapienza, M. T.
    Otaduy, M. C. G.
    Pinto, A. L. de Sa
    Silva, C. A.
    Sallum, A. M. E.
    Pereira, R. M. R.
    Gualano, B.
    LUPUS, 2014, 23 (14) : 1500 - 1511
  • [50] Dehydroepiandrosterone in systemic lupus erythematosus - Results of a double-blind, placebo-controlled, randomized clinical trial
    vanVollenhoven, RF
    Engleman, EG
    McGuire, JL
    ARTHRITIS AND RHEUMATISM, 1995, 38 (12): : 1826 - 1831
12345